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Abstract  
Objective: To examine the effect of a medication synchronization or education program on hypertensive health outcomes.   
Methods: This study used a design of randomized controlled trial lasting four months taking place within a family-owned community 
pharmacy chain in a U.S. Midwestern state.  A total of 302 hypertensive patients were randomized into 3 study groups – control, 
medication synchronization, and education.  Interventions included management of medication refills through a medication 
synchronization program for the medication synchronization group, and monthly hypertension (HTN) education for the education 
group.  Outcome measures included systolic blood pressure (SBP), diastolic blood pressure (DBP), percentage of patients at blood 
pressure (BP) goal, self-rated change in medication adherence, and patients’ HTN knowledge.  Results: All groups had significant 
decline of SBP from baseline; however the final analysis showed no significant SBP differences among study groups. The proportion of 
patients achieving BP goals in both the control (p=0.005) and education (p=0.019) groups increased at Month 4.  Changes in self-
reported adherence were not significant for any groups.  All groups showed positive changes on HTN knowledge questions with the 
education group showing the greatest change. Conclusion: Compared to the control group, there was no difference in the primary 
outcomes.  However, this study demonstrated that educational materials written at an appropriate level and presented by 
community pharmacists to patients may have been associated with an increase in HTN knowledge and a significant increase in the 
proportion of patients achieving their BP goal.  These educational interventions had a greater impact on helping patients achieve 
their blood pressure goals than medication synchronization.   This may indicate that further intervention is needed to impact 
adherence aside from ensuring that patients have their medication on hand.  Taking the time to educate patients about hypertension 
led to self-reported positive change with being more careful about taking medications and with not forgetting to take medications 




In 2010, 60 million American adults were diagnosed with 
hypertension (HTN),1 and the National Heart, Lung, and Blood 
Institute  projected that HTN would cost the U.S. healthcare 
system over $74 billion (USD) annually.2  Between 2000 and 
2010, the population aged 65 years and over increased at a  
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faster rate than the total U.S. population (15.1% versus 
9.7%).3  Sixty percent of U.S. population between the ages of 
60 and 69, 70% between 70 and 79, and 73% 80 years or 
older had HTN.2   
 
Furthermore, medication non-adherence costs the U.S. 
healthcare system $290 billion annually, and patients with 
chronic disease are more likely to be non-adherent.4  Studies 
have shown that over half of patients being treated for 
hypertension discontinue therapy within a year of diagnosis, 
and only half remaining on therapy are >80% adherent to 
antihypertensive medications.5,6  Nonadherence is proposed 
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to be the most common cause of suboptimal response to 
antihypertensive therapy.7  Compounding the issue is a low 
health literacy rate.  According to the U.S. Department of 
Health and Human Services, over 77 million American adults 
have basic or below basic health literacy.8  Low health literacy 
causes a great deal of miscommunication between healthcare 
professionals and their patients, and non-adherence leads to 
poor health outcomes and increased medical costs.4  The 
primary care physician population in the U.S. is dwindling, 
and the number of medical students going into primary care 
has dropped by over 50% within the past decade.9  An aging 
patient population coupled with declining numbers of 
primary care physicians may limit access to health care for 
many patients.   
 
The accessibility of community pharmacists puts them in a 
unique position to help fill the gap in primary healthcare.  
According to the National Association of Chain Drug Stores, 
92% of Americans live within five miles of a community 
pharmacy.9  Additionally, the average patient who fills at least 
6 prescriptions over a 12 month period, visits his/her 
pharmacy weekly compared with visiting his/her primary care 
physician every two and a half months.9  Moreover, a 2013 
Gallup poll cited pharmacists as the second most honest and 
ethical profession.10  This level of trust and access places 
community pharmacists in a position to bridge the gap in care 
and provide quality, outcomes-based interventions to their 
patients.   
 
The impact of community pharmacist interventions on health 
outcomes of HTN has been demonstrated as well.  A 
systematic review and meta-analysis in pharmacists’ HTN 
management reveals that medication management and 
education about HTN are the most common interventions.11  
Systolic blood pressure (SBP) was found “definitely-sensitive” 
to pharmacists’ interventions, which suggests the impact of 
pharmacists’ interventions on SBP are clinically important and 
statistically significant.  Another systematic review and meta-
analysis indicates education about HTN medications by 
nurses or pharmacists reduces blood pressure (BP).12  Using a 
cluster randomized, controlled clinical trial, Carter et al. 
reported that a physician-pharmacist collaborative 
intervention achieved better BP control.13  In addition, 
Svarstad et al. used a cluster randomized trial to examine 
community pharmacists’ intervention of education and 
adherence monitoring for black hypertensive patients.14  They 
found that the intervention had a positive impact on 
improving refill adherence and lowering SBP.     
 
A 2008 Cochrane collaboration reviewed studies that aimed 
to impact change in medication adherence.15  Interventions 
for hypertensive patients included complicated, time 
intensive intervention, simplifying regimens, phone 
reminders and education, home BP monitoring and use of 
blister packaging.  None of the studies cited use of 
medication synchronization as an intervention.  Medication 
synchronization involves pharmacists working with patients 
to coordinate chronic refill medications to come due on a 
single day of the month.16  A study by Holdford and Inocencio 
demonstrated that the use of an appointment-based 
medication synchronization program in community pharmacy 
was associated with improved adherence and reduced 
likelihood of nonpersistence.16 
 
Objective 
The objective of this study was to examine the effect of a 
medication synchronization program or an education 
program on hypertensive patients’ health outcomes.  These 
outcomes included SBP, diastolic blood pressure (DBP), 
proportion of patients at BP goal, change in self-rated 
medication adherence, and patients’ knowledge of HTN-
related topics.  The authors hypothesized education and 
medication synchronization interventions would produce 
significant SBP lowering compared to a control group.   
 
Methods 
Study Population and Study Design 
The study took place at a family-owned, 15 store community 
pharmacy chain in northwest-central Missouri and was 
approved by the University of Missouri—Kansas City’s Adult 
Health Sciences Institutional Review Board.  Patients were 
enrolled at six retail locations and randomized by research 
staff into three groups based on enrollment order: control, 
medication synchronization, or education.  Randomization 
occurred at the patient level, and within each pharmacy.  
Patients were given a number based on the order of 
enrollment and were not blinded to other groups.  For 
example, the first person was assigned to group one 
(control), second to group two (medication synchronization), 
third to group three (education), fourth to group one 
(control), and so on.  Study recruitment and follow-up lasted 
from January 2012-June 2012.  Study locations were chosen 
based upon clinical staffing levels and availability to complete 
the study in the four-month time frame.  The inclusion 
criteria were: 18 years of age or older, diagnosis of HTN 
inferred by medication use, prescribed at least one BP 
medication, and filled two or more prescriptions at the study 
site.  Excluded patients were less than 18 years of age, had 
limitations to diet or exercise modification, experienced a 
heart attack or stroke within the six months prior to 
enrollment, had kidney failure or were on dialysis.  Eligible 
patients received an invitation letter to participate and study 
participants received an automatic BP monitor for home use 
upon completing all visits as an incentive for participation.     
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Study Interventions 
All study participants completed a baseline and final 
questionnaire assessing their adherence to medication and 
knowledge of HTN.  Additionally, all patients received 
monthly blood pressure measurement, four times in total, to 
allow for comparisons in clinical data between groups.17  Two 
readings were taken at each visit with an automatic BP 
monitor, HoMedics BP-060 (HoMedics, Inc.; Commerce 
Township, Michigan).  An automatic meter was selected 
instead of stethoscope and sphygmomanometer to reduce 
variability between pharmacists taking BP readings.  All 
participating pharmacists were trained by one researcher on 
appropriate use of this specific meter to ensure fidelity of 
measurements.  Each patient was measured for correct cuff 
size, and monitored using an adult regular or adult large BP 
cuff.  The readings were obtained one to two minutes apart, 
after an initial five minute resting period, with feet flat on the 
floor, and without talking.  If the two SBP readings had 
greater than 6 mmHg difference, a third reading was taken, 
and the two values closest in range were recorded.  
Hypertensive patients, or those with comorbidities including 
diabetes, were assigned a goal of less than 140/90 or 130/80 
mmHg, respectively.18 
 
Control group patients did not receive additional intervention 
beyond monthly blood pressure checks assessed on a walk-in 
basis.  Essentially this served as a feedback loop where 
control patients received feedback about their blood 
pressure.  They were not reminded to come to the pharmacy 
to refill medications or to have their blood pressure 
measured.  Medication synchronization group patients had all 
of their maintenance medication fills, including 
antihypertensive medication(s), synchronized to the one day 
each month that worked best for them to pick up all of their 
medications.  This is referred to as the Appointment Based 
Model (ABM).19  Prior to the appointment day, the patient 
was then called by a pharmacy staff member to determine if 
any medication changes occurred since the last month’s 
appointment.  This process reduced lapses in treatment by 
allowing the pharmacy staff to be proactive if a medication 
was in need of a refill or prior authorization.  Additionally, 
refilling all medications on the same date allowed for monthly 
reviews of patients’ complete current medications.  The 
patient was then notified via phone call, or if preferred via 
text messaging, when all of the medications were ready to be 
picked up.  BPs were measured for medication 
synchronization patients monthly upon picking up their 
medications.  Education group patients received a monthly 
education session covering various topics related to HTN and 
improving hypertensive health outcomes, were given 
education materials to take home, and had their knowledge 
assessed at the visit.  Education visits were conducted by a 
pharmacist and occurred concurrently with the BP 
measurement, on a walk-in basis.  These patients were only 
asked to complete BP assessments if they were in the 
pharmacy filling prescriptions.  They were not reminded to 
pick up prescriptions or to come to the pharmacy for BP 
visits.  Education sessions were performed based upon a set 
of four patient handouts.  Pharmacists provided an overview 
and discussion with each patient about the information 
contained within one handout during their monthly visit.  The 
handout was then provided to the patient to take home and 
use as a reference.  Handouts were presented within a 10-15 
minute timeframe, and allowed comprehensive patient 
education without adversely affecting pharmacy workflow.  
Additionally, education patients completed a pre and post-
test regarding the education topic to assess baseline 
knowledge and retention of information presented.  
Questions asked before and after education sessions were 
directly related to the monthly education topic presented.  
The same pharmacist did not perform every education 
session; however, one researcher trained all participating 
pharmacists to perform the sessions.  The standardized 
training provided consistency to the education sessions.  The 
handouts were presented in the following order: the basics of 
BP, lifestyle modification through diet, lifestyle modification 
through exercise, and the importance of medication 
adherence.  All handout information was derived from the 
American Heart Association (AHA) and the JNC-7 
hypertension guidelines.18,20  Each topic was written at a fifth 
grade reading level, and printed in color.   
 
For all study groups, patients’ self-reported adherence to 
medication regimens was measured via the Morisky, Green, 
and Levine (MGL) Adherence Scale.21  The MGL is a series of 
four yes/no questions, scored zero through four, which were 
incorporated into the baseline and final questionnaires.  If 
patients answered “yes” to any question, they were more 
likely to be non-adherent.21  Adherence was measured by a 
self-rated scale alone because measuring prescription refill 
history would show perfect adherence within the medication 
synchronization group due to the nature of the intervention.  
 
Patients’ knowledge of topics related to HTN was assessed in 
the baseline and final questionnaire with a series of five 
questions related to BP goals, influence of diet and exercise 
on BP, complications of uncontrolled HTN, and identification 
of BP medications.  The knowledge questions were derived 
from the AHA website, and correspond with questions asked 
on pre/post-tests administered during education visits.20   All 
education topics and HTN knowledge pre/post-tests were 
reviewed by clinical staff, non-clinical staff, and lay people for 
clarity and relevance prior to administration to patients.   
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Outcomes 
The main outcome measures of this study are systolic blood 
pressure (SBP), diastolic blood pressure (DBP), percentage of 
patients at blood pressure (BP) goal, self-rated change in 
medication adherence, and patients’ HTN knowledge.   
 
Statistical Analysis 
Sample size was estimated by an ANOVA test with a detected 
change in SBP of 6 mmHg between the education group and 
the medication synchronization or control group,22 a SBP 
standard deviation of 15 mmHg,22 an alpha of 0.05, and a 
beta of 20%.  A total of 276 patients, or 92 patients per study 
group, were needed and a sample size of 300 patients, or 100 
patients per group was selected.  Thus each study location 
recruited 50 patients.  Patients’ baseline characteristics were 
reported using descriptive statistics.  One-way ANOVA tests 
compared continuous variables including patient BP among 
groups.  Chi-square tests compared categorical variables 
among groups.  In addition, for each group, since the data of 
SBP and DBP were normally distributed (demonstrated by 
Shapiro-Wilk Test), paired t-tests were performed to compare 
SBP and DBP at baseline versus Month 4.  For each group, 
evaluation of BP goal, and patients’ adherence and 
knowledge at baseline versus Month 4 was assessed via the 
McNemar Chi-square test.  Statistical analyses were 
conducted via a “per-protocol” approach (i.e., patients lost to 
follow up were excluded) and a p-value of <0.05 was 
considered statistically significant.   
 
Results 
Enrollment letters were sent to 6,397 patients and 302 
enrolled to participate in the study.  Three hundred and two 
patients were randomized into the three study groups: 
control, medication synchronization, and education.  At the 
conclusion of the study, 94, 95, and 86 patients in the control 
group, medication synchronization group, and education 
group, respectively, completed all study activities.  Nine, 
seven and eleven patients were lost to follow-up in the 
control, medication synchronization, and education groups 
respectively.  Reasons for loss at follow-up included: patients 
not willing to complete interventions, patients consistently 
not showing for visits, and patients entering long term care 
facilities.  Baseline characteristics of study patients are 
displayed in Table 1.  All baseline characteristics were similar 
among groups.  Patients were generally female, 65 years of 
age, taking at least two BP medications, and had a high school 
education or above.  Of the total study population, 41% were 
male and 27% were diabetic.   
 
All groups had a significant SBP decline (p<0.05) from 
baseline, however there were no significant monthly SBP 
differences among study groups (Table 2).  Also, the control 
group produced significant DBP (p=0.002) decreases from 
baseline, but there were no significant differences among 
study groups at final BP analysis.  For the control group and 
education group, the proportion of patients achieving BP 
goals increased at Month 4 (Table 3).  From the baseline/final 
questionnaire, there were no significant changes in subject 
perception of adherence before and after the intervention for 
any study group (Table 4).  The most commonly reported 
reason for non-adherence was forgetfulness with 50.6% of 
patients reporting this reason.  Control group patients had a 
positive change on 20% of HTN knowledge questions, while 
medication synchronization group patients had a positive 
change on 40%.  The education group improved scores on 
60% of HTN knowledge questions.  Notably, the education 
group experienced a 27.1% increase in correct identification 
of appropriate amount of exercise needed for BP lowering 
(p<0.001).   
 
Discussion 
Our study evaluated the effect of community pharmacist 
intervention on SBP and DBP among groups and from 
baseline, proportion of patients achieving BP goal, and 
patient perception of medication adherence.  In this study all 
groups produced significant SBP lowering from baseline, 
however there were no significant SBP differences among 
study groups.  A significant SBP difference between groups 
may have been seen if only patients with uncontrolled HTN 
were enrolled in the study.  At baseline each study group 
started out with a substantial proportion of patients already 
meeting treatment goals: control 49.0%, medication 
synchronization 41.8%, and education 38.3%.  This may have 
reduced the ability to see improvements across all groups.  
Had only patients with uncontrolled hypertension been 
enrolled there would have been more room for impact.  
However, we felt enabling all patients, even those at goal, to 
take charge of their health through lifestyle was a worthy 
cause and reason to include these patients, if interested in 
participation.   
 
Control group patients had their BPs assessed each month in 
order to provide feedback to the participants regarding what 
their blood pressures are and to compare their clinical data to 
the other groups receiving interventions.  It appears this 
feedback monitoring without additional intervention has 
impacted their blood pressures in a positive way.  This 
reduction in BP may not have been seen if they had simply 
been assessed at baseline and/or at the end of the study 
period.  The proportion of patients achieving BP goals 
significantly increased in the control and education groups 
after the interventions.  Controlling BP to within the goals 
outlined by current HTN guidelines18 is integral to prevention 
of serious target organ damage from uncontrolled HTN.   
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The absence of change in self-reported adherence scores 
within study groups suggests it is difficult to change patient 
adherence by the singular act of synchronizing medications 
and reminding the patient to pick them up when they are 
due.  There is a need for interventions that focus on 
motivation and awareness of the importance of taking 
medication as prescribed in addition to ensuring the patient 
physically has the medication.  With forgetfulness being the 
most commonly reported reason for non-adherence in this 
study, it is important for community pharmacists to 
communicate with patients about barriers to adherence.  The 
proactive nature of the medication synchronization program 
allows the pharmacy staff to prepare for patient 
consultations regarding adherence or other underlying health 
or medication-related issues by knowing when to expect 
these patients at the pharmacy using the ABM.  While 
providing education on medication regimens, community 
pharmacists can impact adherence by suggesting additional 
tools, such as medication planners and alarms, to remind 
patients to take their medications.  Given the need to follow 
the research protocol and measure BP at pick up times, 
adherence was not directly discussed with medication 
synchronization patients; it was only evaluated through the 
study questionnaire.     
 
Based on answers to HTN knowledge questions, patients in 
the education group improved on questions regarding the 
amount of exercise needed to impact BP lowering.  
Awareness of the appropriate amount of exercise may 
influence patients to exercise more, and consequently 
decrease BP.  Exercise is an important component to 
attaining BP control.  Within the education group, 60% of 
knowledge questions on pre/post-tests demonstrated an 
increase in proportion of patients answering the question 
correctly after the intervention.  This indicates that the 
educational materials presented to patients may have 
successfully informed them on various HTN topics.   
 
Limitations 
The short four-month duration was a limitation of this study.  
A longer time period may be necessary to detect significant 
SBP differences between intervention groups at final analysis.  
There may have been selection bias in the study where the 
people who volunteered are likely different from those who 
did not.  This may explain why medication synchronization 
did not have an impact on BP reduction.  The control group 
may have also experienced compensatory rivalry.  Upon 
knowing the other two groups were receiving an additional 
intervention, they may have decided to seek out additional 
intervention on their own or modify their own medication-
taking behaviors.  Another limitation was subject behavioral 
factors that could cause elevated blood pressure were not 
assessed.  These factors might include exercise, caffeine 
intake, stress, and/or nicotine intake within 30 minutes prior 
to BP measurement.  Additionally, although the pharmacists 
performing the interventions were trained prior to 
enrollment by a sole researcher, they were not monitored 
throughout the study to ensure the integrity of design was 
maintained.  
 
For a self-reported adherence measure, such as the MGL, 
patients may be more likely to respond with what the health 
provider would like to hear versus how they actually use 
medications.  Although, completing a paper survey may allow 
the patient to answer more freely than when answered face 
to face.  Despite limitations, steps were taken to minimize the 
amount of bias and incidence of error. This included 
randomization, offering enrollment to all HTN patients at the 
pharmacy, and estimating sample size based on sufficient 
power. 
 
Trending results including decreased blood pressure and 
changes in knowledge are promising, and future studies of 
longer duration and modified study logistics need to be 
conducted to examine differences among study groups.  
Based on the results of this study, a hypertension monitoring 
fee-for-service program was implemented in all pharmacies 
within the organization.  Additionally, it was determined that 
the medication synchronization program needed 
enhancement to include a patient consultation each month 
when medications were picked up to assess adherence, 
changes in regimen, or any additional questions or concerns.   
 
Conclusion 
All groups had significant SBP lowering from baseline to 
Month 4, however there were no significant SBP differences 
among study groups.  Medication synchronization did not 
lead to a significant increase in proportion of patients at BP 
goal.   This may indicate that further intervention is needed to 
impact adherence aside from ensuring that patients have 
their medication on hand.  There were no significant changes 
in self-reported medication adherence in any study groups, 
but the education group reported positive change with being 
more careful about taking medications and with not 
forgetting to take medications when they felt better.  This 
study also demonstrated that educational materials written 
at an appropriate level and presented by community 
pharmacists to patients may have been associated with an 
increase in HTN knowledge and a significant increase in the 
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Age (mean ± SD)b n=288 n=98 n=94 n=96 0.330 
Years 65.5 ± 13 66.2 ± 13 63.9 ± 12 66.4 ± 12  
Gender (%)c n=294 n=101 n=99 n=94 0.818 
Male 41 36 45 42  
BP medications (average #)b n=282 n=96 n=96 n=90 0.259 
Number of medications  2.1 2.1 2.2 1.9  
Time since diagnosis (%)c n=274 n=90 n=96 n=88 0.241 
 <1 year 4.0 2.2 3.4 6.8  
1-2 years 8.4 7.8 6.3 11.4  
3-10 years 42.7 37.8 43.8 46.6  
>10 years 44.9 52.2 46.9 35.2  
Education (%)c n=278 n=93 n=95 n=90 0.286 
No education  1.0 1.1 0 2.2  
Kindergarten through 8th 1.4 2.2 0 2.2  
Some High School  10.1 5.4 16.8 7.7  
High School Graduate  42.1 42.0 45.3 38.9  
Some College  24.8 26.9 23.2 24.4  
College Graduate 14.4 16.1 11.6 15.6  
Post Graduate/Professional  6.1 6.5 3.2 8.9  
Adherencec,d (%)      
Have you ever forgotten to 
take your medication? 
n=290 n=98 n=97 n=95 0.972 
     Yes 53.8 53.1 53.6 54.7  
At times are you not careful 
about taking your 
medications?  
n=290 n=98 n=97 n=95 0.574 
     Yes 15.5 17.3 12.4 16.8  
When you feel better, do you 
sometimes forget to take your 
medications?  
n=289 n=97 n=97 n=95 0.950 
     Yes 9.0 9.3 8.2 9.5  
At times, if you feel worse 
when you take your medicine, 
do you stop taking them? 
n=290 n=98 n=97 n=95 0.479 
     Yes 4.1 5.1 5.2 2.1  
a p <0.05 is statistically significant  
b Evaluated via ANOVA 
c Evaluated via Chi-Square test 
d Measures were derived from: Morisky DE, Green LW, Levine DM. Concurrent and predictive 
validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. 
Abbreviations: SD = Standard deviation  
n varied due to missing data.  
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SBPa,b      
Baseline  138 (n=302) 137 (n=103) 137 (n=102) 139 (n=97) 0.704 
Month 2  133 (n=288) 130 (n=96) 134 (n=98) 136 (n=94) 0.108 
Month 3  129 (n=276) 130 (n=93) 129 (n=96) 129 (n=87) 0.841 
Month 4  130 (n=275) 128 (n=94) 133 (n=95) 129 (n=86) 0.165 
Difference 
between 
baseline and  
Month 4 a,d 
8 9 (p 0.001) 4 (p 0.041) 10 (p <0.001)  
DBPa,b       
Baseline  79 (n=302) 79 (n=103) 79 (n=102) 79 (n=97) 0.871 
Month 2  77 (n=288) 76 (n=96) 77 (n=98) 77 (n=94) 0.681 
Month 3  74 (n=276) 75 (n=93) 75 (n=96) 74 (n=87) 0.822 




Month 4 a,d 
3 3 (p 0.002) 2 (p 0.302) 3 (p 0.083)  
 
a Measured in millimeters of mercury (mmHg) 
b Evaluated via one-way ANOVA 
c p<0.05 is statistically significant, and significant p vales were bolded. 
d Evaluated via paired t-test 
Abbreviations used: SBP = systolic blood pressure; DBP = diastolic blood pressure 
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Have you ever forgotten to take your 
medication? 
4.7 0.503 1.3 1.000 7.9 0.210 
At times are you not careful about taking 
your  medications? 
-8.2 0.167 0.0 1.000 -5.4 0.424 
When you feel better, do you sometimes 
forget to take your medications?  
1.2 1.000 2.6 0.754 -5.4 0.344 
At times, if you feel worse when you take 
your medicine, do you stop taking them? 
1.2 1.000 2.6 0.727 2.7 0.687 
Knowledgeb,d 
What is your goal blood pressure? 
2.4 0.804 2.5 0.791 1.3 1.000 
What foods/drinks can cause your blood 
pressure to go up? 
13.8 0.050 19.8 0.005 18.5 0.011 
What problems cannot be caused by high 
blood pressure? 
-3.4 0.678 11.1 0.078 11.1 0.064 
Which of these is a blood pressure 
medication?  
19.5 0.002 25.9 0.000 34.6 0.000 
How often should you exercise to 
decrease your blood pressure?  
-5.7 0.442 6.2 0.473 27.1 0.000 
a Measures were derived  from: Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-
reported measure of medication adherence. Med Care. 1986;24:67-74. 
b Evaluated via Chi-Square test 
c p<0.05 is statistically significant, and significant p values were bolded. 




Table 3. Proportion of subjects achieving blood pressure goalsa 
 
Group 
Baseline at goal  
(%) 






Control (nb=96) 49.0 70.8 21.8 0.005 
Medication synchronization 
(nb=98) 
41.8 60.2 18.4 0.185 
Education (nb=94) 38.3 61.7 23.4 0.019 
a Blood pressure goals: <140/90 mmHg (non-diabetic), <130/80 mmHg (diabetic) 
b n was determined by including all subjects with at least 2 recorded blood pressure readings  
c Patients at blood pressure goal at month four that had received at least two measurements: baseline 
and month four 
d p<0.05 is statistically significant, and significant p vales were bolded. 
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